Page last updated: 2024-09-05

sb 203580 and verlukast

sb 203580 has been researched along with verlukast in 2 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (verlukast)	Trials (verlukast)	Recent Studies (post-2010) (verlukast)
3,489	4	1,137	396	14	115

Protein Interaction Comparison

Protein	Taxonomy	sb 203580 (IC50)	verlukast (IC50)
Multidrug resistance-associated protein 1	Homo sapiens (human)		2.8

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dokter, W; Müller, M; Tuyt, L; Vellenga, E; Wierenga, BJ	1
Austen, KF; Boyce, JA; Frank, N; Hodge, MR; Lora, JM; Mellor, EA; Soler, D	1

Other Studies

2 other study(ies) available for sb 203580 and verlukast

Article	Year
Interleukin-6 production by activated human monocytic cells is enhanced by MK-571, a specific inhibitor of the multi-drug resistance protein-1. British journal of pharmacology, 1999, Volume: 127, Issue:2 Topics: ATP-Binding Cassette Transporters; Blotting, Northern; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; In Vitro Techniques; Interleukin-6; Leukotriene C4; Lipopolysaccharides; Monocytes; Multidrug Resistance-Associated Proteins; Phosphorylation; Propionates; Proto-Oncogene Proteins c-jun; Pyridines; Quinolines; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Stimulation, Chemical; Up-Regulation	1999
Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proceedings of the National Academy of Sciences of the United States of America, 2003, Sep-30, Volume: 100, Issue:20 Topics: Enzyme Inhibitors; Humans; Imidazoles; Leukotriene Antagonists; Mast Cells; Membrane Proteins; Mitogen-Activated Protein Kinases; Phosphorylation; Propionates; Pyridines; Quinolines; Receptors, Leukotriene; RNA, Messenger	2003

Article

Year

Interleukin-6 production by activated human monocytic cells is enhanced by MK-571, a specific inhibitor of the multi-drug resistance protein-1.

British journal of pharmacology, 1999, Volume: 127, Issue:2

Topics: ATP-Binding Cassette Transporters; Blotting, Northern; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; In Vitro Techniques; Interleukin-6; Leukotriene C4; Lipopolysaccharides; Monocytes; Multidrug Resistance-Associated Proteins; Phosphorylation; Propionates; Proto-Oncogene Proteins c-jun; Pyridines; Quinolines; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Stimulation, Chemical; Up-Regulation

1999

Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R.

Proceedings of the National Academy of Sciences of the United States of America, 2003, Sep-30, Volume: 100, Issue:20

Topics: Enzyme Inhibitors; Humans; Imidazoles; Leukotriene Antagonists; Mast Cells; Membrane Proteins; Mitogen-Activated Protein Kinases; Phosphorylation; Propionates; Pyridines; Quinolines; Receptors, Leukotriene; RNA, Messenger

2003